Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosis

2018 ◽  
Vol 117 (8) ◽  
pp. 1648-1654 ◽  
Author(s):  
Rebecca A. Snyder ◽  
Laura R. Prakash ◽  
Graciela M. Nogueras-Gonzalez ◽  
Michael P. Kim ◽  
Thomas A. Aloia ◽  
...  
Keyword(s):  
Pancreatic Adenocarcinoma ◽  
Vein Resection

Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection

2019 ◽  
Vol 24 (2) ◽  
pp. 368-379 ◽  
Author(s):  
Laura R. Prakash ◽  
Huamin Wang ◽  
Jun Zhao ◽  
Graciela M. Nogueras-Gonzalez ◽  
Jordan M. Cloyd ◽  
...  
Keyword(s):  
Cancer Cells ◽  
Pancreatic Adenocarcinoma ◽  
Vein Resection

scholarly journals Superior Mesenteric-Portal Vein Resection in Patients With Pancreatic Adenocarcinoma Is Safe and May Increase Survival

2017 ◽  
Vol 102 (7-8) ◽  
pp. 356-361
Author(s):  
Wei-Ding Wu ◽  
Hong-Guo Yang ◽  
Jia Wu ◽  
Kai Jiang ◽  
Kun Guo ◽  
...  
Keyword(s):  
Portal Vein ◽  
Pancreatic Adenocarcinoma ◽  
Survival Rates ◽  
Vein Wall ◽  
Venous Resection ◽  
Group A ◽  
Tumor Involvement ◽  
Artery First ◽  
Vein Resection ◽  
Group B

Extension of pancreatic adenocarcinoma into adjacent vasculature often necessitates resection of the portal vein (PV) and or superior mesenteric vein (SMV) during pancreaticoduodenectomy (PD). Our study describes the surgical technique and results of PV/SMV resection in pancreatic adenocarcinoma patients. Between January 2008 and October 2013, 252 patients underwent PD for pancreatic malignancy. A total of 42 PV/SMV resections were performed (28 men, 14 women). Patients were categorized into 2 groups according to the degree of invasion into the portal vein wall: Group A (n = 16), extended compression of the portal vein wall by the surrounding carcinoma without true invasion, and Group B (n = 26), true invasion including intramural and transmural invasion. Morbidity of the 42 patients was 35%; there was no operative mortality, and overall 1-, 3-, and 5-year survival rates were 60%, 21%, and 12%, respectively. No differences in tumor size, margin positivity, nodal positivity, or survival rates were observed between groups. Resection of the PV/SMV is safe and does not increase morbidity or mortality. Tumor involvement of the PV/SMV is not associated with histopathologic signs that are predictive of a poor prognosis. The “artery first” approach should be considered as a means to facilitate safe venous resection and reconstruction.

Pancreaticoduodenectomy With Portal Vein Resection for Pancreatic Adenocarcinoma: A 10-Year Experience

2013 ◽  
Vol 179 (2) ◽  
pp. 194
Author(s):  
M. Melis ◽  
A. Pinna ◽  
F. Marcon ◽  
G. Miller ◽  
S.M. Cohen ◽  
...  
Keyword(s):  
Portal Vein ◽  
Pancreatic Adenocarcinoma ◽  
Portal Vein Resection ◽  
Vein Resection

scholarly journals Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization

HPB ◽  
2019 ◽  
Vol 21 (7) ◽  
pp. 841-848
Author(s):  
Rebecca A. Snyder ◽  
Laura R. Prakash ◽  
Graciela M. Nogueras-Gonzalez ◽  
Michael P. Kim ◽  
Thomas A. Aloia ◽  
...  
Keyword(s):  
Pancreatic Adenocarcinoma ◽  
Blood Transfusions ◽  
Vein Resection

scholarly journals Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?

2016 ◽  
Vol 128 (15-16) ◽  
pp. 566-572 ◽  
Author(s):  
Katharina Marsoner ◽  
Rainer Langeder ◽  
Dora Csengeri ◽  
Gottfried Sodeck ◽  
Hans Jörg Mischinger ◽  
...  
Keyword(s):  
Portal Vein ◽  
Pancreatic Adenocarcinoma ◽  
Portal Vein Resection ◽  
Vein Resection ◽  
Advanced Pancreatic Adenocarcinoma
Sign in / Sign up

Export Citation Format

Share Document